MYEOV Polyklonaler Antikörper
MYEOV Polyklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 11151-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
11151-1-PBS bindet in WB, IHC, Indirect ELISA MYEOV und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | MYEOV fusion protein Ag1498 |
| Vollständiger Name | myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas) |
| Berechnetes Molekulargewicht | 33 kDa |
| Beobachtetes Molekulargewicht | 55-60 kDa |
| GenBank-Zugangsnummer | BC011815 |
| Gene symbol | MYEOV |
| Gene ID (NCBI) | 26579 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MYEOV, also named as OCIM, was originally isolated by the application of the NIH/3T3 tumorigenicity assay with DNA from a gastric carcinoma. It is a prognostic factor for patients with multiple myeloma, in part through a role of MYEOV in the control of MMC proliferation. MYEOV is a candidate oncogene activated in the amplification core located proximal toCCND1. The observed MW of this protein is 55 kDa(PMID: 20854874 ).





